The Effect of Long Acting Injectable Psychotropic Medication Provider Education on Advanced Practice Provider Knowledge
Year: 2019
Type: article
Study design: Clinical Trial
Abstract: Schizophrenia is a debilitating disease that affects approximately 21 million people worldwide (APA, 2013). The gold standard of treatment of schizophrenia is antipsychotic medications. Unfortunately, approximately 50% of patients become non-compliant with their prescribed medications (Sadock, Sadock & Ruiz, 2015). The purpose of this DNP project was to determine the effect of implementing an education intervention regarding long acting injectable (LAI) antipsychotics on the knowledge of advanced practice providers working at a state psychiatric hospital. The advanced practice providers that participated in this DNP project completed a pre-education assessment, attended a brief educational session regarding LAI antipsychotics, and completed a post-education assessment two weeks later. Though the results were limited by the number of participants, it was found that after implementing an educational session regarding LAI antipsychotics advanced practice providers had improved knowledge about and self-efficacy in prescribing of LAI antipsychotics, and reported a greater willingness to prescribe LAI antipsychotics in the future.
Author: A Makowski
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2943718972